48.40000 EUR
4.2
9.50%
Last update Dec 16, 8:14 AM CET
Market closed
Day range
48.40000
48.40000
Previous close
44.20000
Open
48.40000
Access this stock data via API
Subscribe
Nektar Therapeutics Inc.
48.40
4.20
9.50%

Financials

Income statement

Fundamentals currency is USD
Fiscal date 2024
Total reported revenue 83.9M
Cost of revenue 26.2M
Gross profit 57.7M
Operating expense
Research & development 103.0M
Selling general and admin 65.4M
Other operating expenses
Operating income -110.7M
Non operating interest income
Income 12.4M
Expense 24.0M
Other income expense 20.7M
Pretax income -101.6M
Tax provision -203.7K
Net income -101.4M
Basic EPS -8.7
Diluted EPS -8.7
Basic average shares 11.7M
Diluted average shares 11.7M
EBITDA -95.0M
Net income from continuing op. -101.4M
Minority interests
Preferred stock dividends
Access /income_statement data via our API — starting from the Pro plan.
Market closed

Exchange is currently closed
Main market opens in 8 hours 17 minutes

23:42
00:00
08:00
22:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 22:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).